Cardiac differentiation of human pluripotent stem cells in scalable suspension culture
暂无分享,去创建一个
Robert Zweigerdt | Christina Kropp | R. Zweigerdt | U. Martin | Ulrich Martin | Henning Kempf | Ruth Olmer | H. Kempf | C. Kropp | R. Olmer
[1] S. Yuasa,et al. A Massive Suspension Culture System With Metabolic Purification for Human Pluripotent Stem Cell‐Derived Cardiomyocytes , 2014, Stem cells translational medicine.
[2] S. Gerecht,et al. Scalable expansion of human induced pluripotent stem cells in the defined xeno-free E8 medium under adherent and suspension culture conditions. , 2013, Stem cell research.
[3] Gesine Hansen,et al. Large-Scale Hematopoietic Differentiation of Human Induced Pluripotent Stem Cells Provides Granulocytes or Macrophages for Cell Replacement Therapies , 2015, Stem cell reports.
[4] T. Cantz,et al. Bronchoalveolar sublineage specification of pluripotent stem cells: effect of dexamethasone plus cAMP-elevating agents and keratinocyte growth factor. , 2015, Tissue engineering. Part A.
[5] J. Clemente,et al. Improving expansion of pluripotent human embryonic stem cells in perfused bioreactors through oxygen control. , 2010, Journal of biotechnology.
[6] S. Reuveny,et al. An intermittent rocking platform for integrated expansion and differentiation of human pluripotent stem cells to cardiomyocytes in suspended microcarrier cultures. , 2014, Stem cell research.
[7] Elena Naumovska,et al. Small-Molecule-Driven Hepatocyte Differentiation of Human Pluripotent Stem Cells , 2015, Stem cell reports.
[8] Robert Zweigerdt,et al. Large scale production of stem cells and their derivatives. , 2009, Advances in biochemical engineering/biotechnology.
[9] Lauren I. Siniscalchi,et al. Passaging and colony expansion of human pluripotent stem cells by enzyme-free dissociation in chemically defined culture conditions , 2012, Nature Protocols.
[10] T. Cantz,et al. Concise Review: Cell Therapies for Hereditary Metabolic Liver Diseases—Concepts, Clinical Results, and Future Developments , 2015, Stem cells.
[11] Gordon Keller,et al. Production of de novo cardiomyocytes: human pluripotent stem cell differentiation and direct reprogramming. , 2012, Cell stem cell.
[12] Robert Zweigerdt,et al. Up-scaling single cell-inoculated suspension culture of human embryonic stem cells. , 2010, Stem cell research.
[13] J. Itskovitz‐Eldor,et al. Dynamic suspension culture for scalable expansion of undifferentiated human pluripotent stem cells , 2011, Nature Protocols.
[14] Robert Zweigerdt,et al. Your heart on a chip: iPSC-based modeling of Barth-syndrome-associated cardiomyopathy. , 2014, Cell stem cell.
[15] Praveen Shukla,et al. Chemically defined generation of human cardiomyocytes , 2014, Nature Methods.
[16] Sean P. Palecek,et al. Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling , 2012, Proceedings of the National Academy of Sciences.
[17] Ludovic Vallier,et al. Production of hepatocyte-like cells from human pluripotent stem cells , 2013, Nature Protocols.
[18] C. Schreurs,et al. Dual Reporter MESP1mCherry/w‐NKX2‐5eGFP/w hESCs Enable Studying Early Human Cardiac Differentiation , 2015, Stem cells.
[19] Robert Zweigerdt,et al. Differentiation and lineage selection of mouse embryonic stem cells in a stirred bench scale bioreactor with automated process control. , 2005, Biotechnology and bioengineering.
[20] Robert Zweigerdt,et al. Suspension culture of human pluripotent stem cells in controlled, stirred bioreactors. , 2012, Tissue engineering. Part C, Methods.
[21] Stefan Wagner,et al. Murine and human pluripotent stem cell-derived cardiac bodies form contractile myocardial tissue in vitro. , 2013, European heart journal.
[22] H. Snoeck,et al. The in vitro generation of lung and airway progenitor cells from human pluripotent stem cells , 2015, Nature Protocols.
[23] Robert Zweigerdt,et al. Controlling Expansion and Cardiomyogenic Differentiation of Human Pluripotent Stem Cells in Scalable Suspension Culture , 2014, Stem cell reports.
[24] R. Passier,et al. NKX2-5eGFP/w hESCs for isolation of human cardiac progenitors and cardiomyocytes , 2011, Nature Methods.
[25] S. Taverna,et al. Rapid and efficient CRISPR/Cas9 gene inactivation in human neurons during human pluripotent stem cell differentiation and direct reprogramming , 2016, Scientific Reports.
[26] A. Schambach,et al. Improved hepatic differentiation strategies for human induced pluripotent stem cells. , 2013, Current molecular medicine.
[27] George A. Truskey,et al. Modeling the mitochondrial cardiomyopathy of Barth syndrome with iPSC and heart-on-chip technologies , 2014, Nature Medicine.
[28] Eugenia Kumacheva,et al. Generation of human embryonic stem cell‐derived mesoderm and cardiac cells using size‐specified aggregates in an oxygen‐controlled bioreactor , 2009, Biotechnology and bioengineering.
[29] D K Robinson,et al. Industrial choices for protein production by large-scale cell culture. , 2001, Current opinion in biotechnology.
[30] Andre Choo,et al. Scalable platform for human embryonic stem cell differentiation to cardiomyocytes in suspended microcarrier cultures. , 2010, Tissue engineering. Part C, Methods.
[31] Robert Zweigerdt,et al. Global Expression Profile of Highly Enriched Cardiomyocytes Derived from Human Embryonic Stem Cells , 2009, Stem cells.
[32] R. David,et al. Directing cardiomyogenic differentiation of human pluripotent stem cells by plasmid-based transient overexpression of cardiac transcription factors. , 2013, Stem cells and development.
[33] Thomas Scheper,et al. Long term expansion of undifferentiated human iPS and ES cells in suspension culture using a defined medium. , 2010, Stem cell research.
[34] D. Melton,et al. Generation of Functional Human Pancreatic β Cells In Vitro , 2014, Cell.
[35] C. Hengstenberg,et al. Generation of Highly Purified Human Cardiomyocytes from Peripheral Blood Mononuclear Cell-Derived Induced Pluripotent Stem Cells , 2015, PloS one.
[36] Stefan Wagner,et al. Generation of induced pluripotent stem cells from human cord blood. , 2009, Cell stem cell.
[37] Peter W. Zandstra,et al. Derivation, expansion and differentiation of induced pluripotent stem cells in continuous suspension cultures , 2012, Nature Methods.
[38] S. Houser,et al. Embryonic stem cell-derived cardiac myocytes are not ready for human trials. , 2014, Circulation research.
[39] T. Braun,et al. Cardiomyocyte production in mass suspension culture: Embryonic stem cells as a source for great amounts of functional cardiomyocytes , 2005 .
[40] R. Weissmann,et al. Cleavage of E-Cadherin and β-Catenin by Calpain Affects Wnt Signaling and Spheroid Formation in Suspension Cultures of Human Pluripotent Stem Cells* , 2014, Molecular & Cellular Proteomics.
[41] P. Rosenfeld,et al. Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1/2 studies , 2015, The Lancet.
[42] Vincent C. Chen,et al. Scalable GMP compliant suspension culture system for human ES cells. , 2012, Stem cell research.
[43] Robert Zweigerdt,et al. Scalable expansion of human pluripotent stem cells in suspension culture , 2011, Nature Protocols.
[44] Charles E. Murry,et al. Human Embryonic Stem Cell-Derived Cardiomyocytes Regenerate Non-Human Primate Hearts , 2014, Nature.
[45] Christine L Mummery,et al. Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: a methods overview. , 2012, Circulation research.
[46] Kerry A Chester,et al. Production of recombinant protein in Pichia pastoris by fermentation , 2006, Nature Protocols.
[47] Sean P. Palecek,et al. Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/β-catenin signaling under fully defined conditions , 2012, Nature Protocols.